"/> Novus Biologicals™ Peptide bloquant d’anticorps IR… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps IRAK4

Réf. : BL-RE-104763Réf. fabricant : 18288715 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
51135
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-77231. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide from amino acids near the carboxy terminus human IRAK-4.

Points forts

Source

Synthetic

(Accession #: AAM15772) The IRAK4 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-104763
Réf. fabricant18288715
Gene ID (Entrez)51135
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-77231. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneEC 2.7.11, EC 2.7.11.1, interleukin-1 receptor-associated kinase 4, IPD1, IRAK-4, NY-REN-64, REN64, Renal carcinoma antigen NY-REN-64
Symbole de gène(s)IRAK4
Type de produitIRAK4
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
ConsigneAmino acids near the carboxy terminus of human IRAK-4
Une question, une configuration particulière ?
Contactez-nous pour un devis.